| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.47 | 0.03 |